ImageneBio (IMA) Research & Development (2020 - 2025)

ImageneBio has disclosed Research & Development across 6 years of filings, most recently posting $15.6 million for Q3 2025.

• In Q3 2025, Research & Development rose 300.46% year-over-year to $15.6 million; the TTM figure through Sep 2025 stood at $27.8 million (down 26.2% YoY), while the FY2024 annual figure was $30.9 million, down 48.24% from the prior year.
• Research & Development came in at $15.6 million for Q3 2025 at ImageneBio, up from $5.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $18.8 million in Q3 2022 to a low of $2.5 million in Q4 2024.
• Average Research & Development over 5 years is $11.7 million, with a median of $13.4 million recorded in 2021.
• Year-over-year, Research & Development tumbled 82.31% in 2024 and surged 300.46% in 2025.
• Over 5 years, Research & Development stood at $12.3 million in 2021, then advanced by 26.75% to $15.6 million in 2022, then fell by 8.73% to $14.3 million in 2023, then tumbled by 82.31% to $2.5 million in 2024, then soared by 516.16% to $15.6 million in 2025.
• Per Business Quant data, the three most recent Research & Development figures were $15.6 million in Q3 2025, $5.7 million in Q2 2025, and $4.0 million in Q1 2025.